GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
T

Teleflex TFX · USD

Health Care · US listing · 🇺🇸 United States

Compare

154.73

+2.56%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Teleflex

From its filings with the US Securities and Exchange Commission

SEC filings

Teleflex is based in Wayne, Pennsylvania and is incorporated in Delaware. Its shares trade on NYSE under the ticker TFX. The SEC classifies its business as surgical & medical instruments & apparatus. In the fiscal year to 31 December 2025, it reported revenue of $1.99bn and a net loss of $905.6m. At that date it held total assets of $6.95bn and shareholders' equity of $3.12bn. By business, Vascular Access brought in 46.1% of revenue, followed by Interventional at 32.5% and Surgical at 21.0%. By region, UNITED STATES accounted for 59.3%, followed by Europe at 24.3% and Asia Pacific at 10.9%.

In its own words

Teleflex is a global provider of medical technology products that enhance clinical benefits, improve patient and provider safety and reduce total procedural costs. We primarily design, develop, manufacture and supply single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. We market and sell our products to hospitals and healthcare providers worldwide through a combination of our direct sales force and distributors. Because our products are used in numerous markets and for a variety of procedures, we are not dependent upon any one end-market or procedure. Our major manufacturing operations are located in the Czech Republic, Malaysia, Mexico and the United States (the "U.S.").

Our research and development capabilities, commitment to engineering excellence and focus on low-cost manufacturing enable us to bring to market cost effective, innovative products that improve the safety, efficacy and quality of healthcare. Our research and development initiatives focus on developing these products for both existing and new therapeutic applications, as well as developing enhancements to, and product line extensions of, existing products. Our portfolio of existing products and products under development consists primarily of Class I and Class II medical devices, most of which require 510(k) clearance by the U.S. Food and Drug Administration ("FDA") for sale in the U.S., and some of which are exempt from the requirement to obtain 510(k) clearance.

Quoted from its 10-K, filed 27 Feb 2026. Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
22 May 1981
Employees
15,500
Head office
550 E SWEDESFORD RD, WAYNE, PA, 19087
Incorporated in
DE
Classification
Surgical & Medical Instruments & Apparatus
Filer status
Large accelerated filer

Leadership

Pay as last reported

  • Mr. Liam KellyChairman of the Board, President, Chief Executive Officer, since 2012$9.2m
  • Mr. John DerenChief Financial Officer, Executive Vice President
  • Mr. Daniel LogueCorporate Vice President, General Counsel and Secretary$2.0m
  • Mr. Cameron HicksCorporate Vice President - Human Resources and Communications$1.3m
  • Mr. Jay WhiteCorporate Vice President and President, Global Commercial$2.4m
  • Mr. James WintersCorporate Vice President - Manufacturing and Supply Chain$2.1m
  • Dr. Stephen KlaskoLead Independent Director$313,544
  • Ms. Candace DuncanIndependent Director$326,044
  • Ms. Gretchen HaggertyIndependent Director$302,544
  • Mr. John HeinmillerIndependent Director$301,544
  • Mr. Andrew KrakauerIndependent Director$300,544
  • Ms. Neena PatilIndependent Director$297,544

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
62
Environment
58
Social
87
Governance
41
Direct emissions (scope 1)
16,256 t
Energy emissions (scope 2)
53,983 t
Women in the workforce
58.8%
Carbon reduction policy
Yes
Human rights policy
Yes

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Teleflex Inc has established itself as a leading player in the medical technology industry, enjoying a strong market presence and a favorable brand reputation. This positions the company well to attract customers and gain a competitive edge over its rivals.
  • Teleflex Inc offers a wide range of medical devices and solutions, catering to various healthcare needs. This extensive product portfolio allows the company to target multiple market segments and diversify its revenue streams, reducing dependence on specific products or markets.

Weaknesses

  • Teleflex Inc's business is reliant on key customers and contracts, which exposes the company to potential risks if these customers reduce their orders or switch to competitors. This dependence can limit the company's flexibility in negotiating terms and pricing.
  • As a medical technology company, Teleflex Inc operates in a highly regulated industry. Adherence to strict regulations and potential changes in regulatory frameworks can create challenges for the company, impacting its product development and market access.

Opportunities

  • The global healthcare market is witnessing significant growth, driven by increasing healthcare expenditures and a rise in the aging population. Teleflex Inc can capitalize on this opportunity by expanding its product offerings and entering new markets, fueling revenue growth.
  • Rapid advancements in medical technology offer Teleflex Inc a chance to innovate and introduce new products or enhance existing ones. By staying at the forefront of technological developments, the company can attract customers seeking state-of-the-art medical devices and gain a competitive advantage.

Threats

  • Teleflex Inc operates in a highly competitive market with numerous global and regional players. The intense competition can impact pricing, market share, and profitability. The company needs to continuously innovate and differentiate itself to withstand competition effectively.
  • Teleflex Inc operates globally, which exposes it to currency exchange rate fluctuations. These fluctuations can affect the company's financial performance, as exchange rate movements impact revenue and profit margins when converting between currencies.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.